Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Decoding the historical tale, COVID-19 impact on haematological malignancy patients-EPICOVIDEHA insights from 2020 to 2022

  • Salmanton-García, Jon|||0000-0002-6766-8297
  • Marchesi, Francesco|||0000-0001-6353-2272
  • Farina, Francesca|||0000-0002-5124-6970
  • Weinbergerová, Barbora|||0000-0001-6460-2471
  • Itri, Federico|||0000-0002-3532-5281
  • Dávila-Valls, Julio|||0000-0002-5185-2073
  • Martín-Pérez, Sonia|||0000-0001-5809-7165
  • Glenthøj, Andreas|||0000-0003-2082-0738
  • Hersby, Ditte Stampe
  • Gomes da Silva, Maria|||0000-0002-6993-2450
  • Nunes Rodrigues, Raquel|||0000-0002-8347-4281
  • López García, Alberto|||0000-0002-5354-5261
  • Córdoba, Raúl|||0000-0002-7654-8836
  • Bilgin, Yavuz M.|||0000-0002-3783-3407
  • Falces Romero, Iker|||0000-0001-5888-7706
  • El-Ashwah, Shaimaa|||0000-0003-2210-1534
  • Emarah, Ziad|||0000-0003-0622-2598
  • Besson, Caroline|||0000-0003-4364-7173
  • Kohn, Milena|||0000-0003-1438-3391
  • van Doesum, Jaap A.|||0000-0003-0214-3219
  • Ammatuna, Emanuele|||0000-0001-8247-4901
  • Marchetti, Monia|||0000-0001-7615-0572
  • Labrador, Jorge|||0000-0002-3696-0287
  • Zambrotta, Giovanni|||0000-0002-8612-2994
  • Verga, Luisa|||0000-0003-1142-8435
  • Jakšić, Ozren|||0000-0003-4026-285X
  • Nucci, Marcio|||0000-0003-4867-0014
  • Piukovics, Klára|||0000-0003-4480-3131
  • Cabirta, Alba|||0000-0001-7198-8894
  • Jiménez, Moraima|||0000-0003-1444-8562
  • Arellano, Elena
  • Espigado, Ildefonso|||0000-0002-4043-6613
  • Blennow, Ola|||0000-0002-7167-7882
  • Nordlander, Anna
  • Meers, Stef|||0000-0003-1754-2175
  • Van Praet, Jens|||0000-0002-7125-7001
  • Aiello, Tommaso Francesco|||0000-0003-4441-6318
  • Garcia-Vidal, Carolina|||0000-0002-8915-0683
  • Fracchiolla, Nicola|||0000-0002-8982-8079
  • Sciumè, Mariarita|||0000-0001-7958-4966
  • Cengiz Seval, Guldane|||0000-0001-9433-2054
  • Žák, Pavel|||0000-0003-4465-5343
  • Buquicchio, Caterina|||0000-0002-3683-5953
  • Tascini, Carlo|||0000-0001-9625-6024
  • Gräfe, Stefanie K.|||0000-0001-7678-0179
  • Schönlein, Martin|||0000-0002-1010-0975
  • Adžić-Vukičević, Tatjana
  • Bonuomo, Valentina|||0000-0001-6491-8337
  • Cattaneo, Chiara|||0000-0003-0031-3237
  • Nizamuddin, Summiya
  • Čerňan, Martin|||0000-0003-2345-1229
  • Plantefeve, Gaetan
  • Prin, Romane
  • Szotkovski, Tomas
  • Collins, Graham|||0000-0002-8803-4234
  • Dargenio, Michelina|||0000-0003-0924-4629
  • Petzer, Verena|||0000-0002-9205-1440
  • Wolf, Dominik|||0000-0002-4761-075X
  • Čolović, Natasha|||0000-0002-1321-4812
  • Prezioso, Lucia|||0000-0003-1660-4960
  • Valković, Toni|||0000-0001-6083-8815
  • Passamonti, Francesco|||0000-0001-8068-5289
  • Méndez, Gustavo Adolfo
  • Sili, Uluhan|||0000-0002-9939-9298
  • Vena, Antonio|||0000-0002-0697-3992
  • Bavastro, Martina
  • Limongelli, Alessandro
  • Duarte, Rafael F.
  • Ledoux, Marie-Pierre|||0000-0002-3261-3616
  • Cvetanoski, Milche
  • Stojanoski, Zlate|||0000-0001-7502-8356
  • Machado, Marina|||0000-0002-8370-2248
  • Batinić, Josip|||0000-0001-5595-9911
  • Magliano, Gabriele|||0000-0002-9129-1530
  • Biernat, Monika M.|||0000-0003-3161-3398
  • Pantic, Nikola|||0000-0001-7798-4026
  • Poulsen, Christian Bjørn|||0000-0001-9785-1378
  • Cuccaro, Annarosa|||0000-0002-0237-1839
  • del Principe, Maria Ilaria|||0000-0002-3958-0669
  • Kulasekararaj, Austin|||0000-0003-3180-3570
  • Ormazabal-Vélez, Irati|||0000-0003-1141-5546
  • Busca, Alessandro|||0000-0001-5361-5613
  • Demirkan, Fatih|||0000-0002-1172-8668
  • Ijaz, Marriyam
  • Klimko, Nikolai|||0000-0001-6095-7531
  • Stoma, Igor|||0000-0003-0483-7329
  • Khostelidi, Sofya|||0000-0001-5794-5396
  • Fernández, Noemí
  • Omrani, Ali S.|||0000-0001-5309-6358
  • Bergantim, Rui|||0000-0002-7811-9509
  • De Jonge, Nick|||0000-0002-9901-0887
  • Fouquet, Guillemette
  • Navrátil, Milan|||0000-0002-2067-1253
  • Abu-Zeinah, Ghaith|||0000-0002-1881-3670
  • Samarkos, Michail|||0000-0001-9630-9712
  • Maertens, Johan|||0000-0003-4257-5980
  • De Ramón-Sánchez, Cristina|||0000-0002-8167-6410
  • Guidetti, Anna|||0000-0002-4195-6397
  • Magyari, Ferenc
  • González-López, Tomás José|||0000-0003-2458-2554
  • Lahmer, Tobias|||0000-0003-1008-5311
  • Finizio, Olimpia|||0000-0003-0990-3620
  • Ali, Natasha|||0000-0003-4990-330X
  • Pinczés, Laszlo Imre
  • Lavilla-Rubira, Esperanza
  • Romano, Alessandra
  • Merelli, Maria|||0000-0003-3907-5264
  • Delia, Mario|||0000-0002-6486-8912
  • Calbacho, Maria|||0000-0001-8106-4863
  • Meletiadis, Joseph
  • Antić, Darko|||0000-0002-2608-1342
  • Hernández Rivas, José Ángel|||0000-0003-4550-757X
  • Marques de Almeida, Joyce
  • Al-Khabori, Murtadha|||0000-0002-2937-8838
  • Hoenigl, Martin|||0000-0002-1653-2824
  • Tisi, Maria Chiara|||0000-0001-8231-6700
  • Khanna, Nina|||0000-0002-2642-419X
  • Barać, Aleksandra|||0000-0002-0132-2277
  • Eisa, Noha|||0000-0003-1243-0158
  • Di Blasi, Roberta|||0000-0001-9001-573X
  • Liévin, Raphaël|||0000-0002-5097-591X
  • Miranda-Castillo, Carolina|||0000-0001-8763-9576
  • Bahr, Nathan C.
  • Lamure, Sylvain|||0000-0001-5980-305X
  • Papa, Mario Virgilio|||0000-0002-1579-2202
  • Yahya, Ayel
  • Aujayeb, Avinash|||0000-0002-0859-5550
  • Novák, Jan
  • Erben, Nurettin
  • Fernández-Galán, María
  • Ribera, Jose-Maria|||0000-0003-1042-6024
  • Rinaldi, Ikhwan
  • Fazzi, Rita
  • Piedimonte, Monica
  • Duléry, Rémy|||0000-0002-5024-1713
  • Gonzaga, Yung|||0000-0003-1416-2118
  • Soto-Silva, Andrés
  • Sapienza, Giuseppe
  • Serris, Alexandra
  • Drgoňa, Ľuboš
  • Groh, Ana
  • Serrano, Laura
  • Gavriilaki, Eleni
  • Tragiannidis, Athanasios|||0000-0003-4294-2605
  • Prattes, Juergen|||0000-0001-5751-9311
  • Coppola, Nicola|||0000-0001-5897-4949
  • Otasevic, Vladimir|||0000-0002-8690-1357
  • Mladenović, Milos
  • Mitrović, Mirjana
  • Mišković, Bojana
  • Jindra, Pavel
  • Zompi, Sofia
  • Sacchi, Maria Vittoria|||0000-0001-8133-3357
  • Krekeler, Carolin
  • Infante, María|||0000-0003-0096-9359
  • García-Bordallo, Daniel
  • Çolak, Gökçe Melis|||0000-0001-9065-374X
  • Mayer, Jiří|||0000-0003-0567-9887
  • Nygaard, Marietta
  • Hanáková, Michaela
  • Ráčil, Zdeněk|||0000-0003-3511-4596
  • Bonanni, Matteo
  • Koehler, Philipp|||0000-0002-7386-7495
  • Rahimli, Laman|||0000-0003-2266-445X
  • Cornely, Oliver A.|||0000-0001-9599-3137
  • Pagano, Livio|||0000-0001-8287-928X
Background: The COVID-19 pandemic heightened risks for individuals with hematological malignancies due to compromised immune systems, leading to more severe outcomes and increased mortality. While interventions like vaccines, targeted antivirals, and monoclonal antibodies have been effective for the general population, their benefits for these patients may not be as pronounced. Methods: The EPICOVIDEHA registry (National Clinical Trials Identifier, NCT04733729) gathers COVID-19 data from hematological malignancy patients since the pandemic's start worldwide. It spans various global locations, allowing comprehensive analysis over the first three years (2020-2022). Findings: The EPICOVIDEHA registry collected data from January 2020 to December 2022, involving 8767 COVID-19 cases in hematological malignancy patients from 152 centers across 41 countries, with 42% being female. Over this period, there was a significant reduction in critical infections and an overall decrease in mortality from 29% to 4%. However, hospitalization, particularly in the ICU, remained associated with higher mortality rates. Factors contributing to increased mortality included age, multiple comorbidities, active malignancy at COVID-19 onset, pulmonary symptoms, and hospitalization. On the positive side, vaccination with one to two doses or three or more doses, as well as encountering COVID-19 in 2022, were associated with improved survival. Interpretation: Patients with hematological malignancies still face elevated risks, despite reductions in critical infections and overall mortality rates over time. Hospitalization, especially in ICUs, remains a significant concern. The study underscores the importance of vaccination and the timing of COVID-19 exposure in 2022 for enhanced survival in this patient group. Ongoing monitoring and targeted interventions are essential to support this vulnerable population, emphasizing the critical role of timely diagnosis and prompt treatment in preventing severe COVID-19 cases. Funding: Not applicable.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Novel PiuC, PirA, and PiuA mutations leading to in vivo cefiderocol resistance progression in IMP-16- and KPC-2-producing Pseudomonas aeruginosa from a leukemic patient

  • Viñes, Joaquim|||0000-0003-0709-5236
  • Herrera, Sabina|||0000-0002-5057-354X
  • Vergara, Andrea|||0000-0002-5046-4490
  • Roca, Ignasi|||0000-0002-1800-1576
  • Vila Estapé, Jordi|||0000-0002-8025-3926
  • Aiello, Tommaso Francesco|||0000-0003-4441-6318
  • Martinez Martinez, Jose Antonio|||0000-0002-7012-9817
  • del Río, Ana
  • Lopera, Carlos
  • Garcia-Vidal, Carolina|||0000-0002-8915-0683
  • Casals-Pascual, Climent|||0000-0002-0867-8954
  • Soriano Viladomiu, Alex|||0000-0002-9374-0811
  • Pitart, Cristina|||0000-0002-3083-7915
Pseudomonas aeruginosa is an opportunistic pathogen capable of causing severe infections in immunocompromised individuals, who often require prolonged antibiotic therapy. The emergence of carbapenemase-producing P. aeruginosa has further complicated the management of nosocomial infections, limiting therapeutic options. Cefiderocol has recently emerged as a promising antipseudomonal agent, using the bacterial iron transport system to gain entry into the cell; however, there have been reports of P. aeruginosa resistant to cefiderocol. We describe the in vivo cefiderocol resistance progression of four consecutive P. aeruginosa isolates from one patient with T-cell acute lymphoblastic leukemia. Analysis of potential genes involved in cefiderocol transport resulted in three genes mutated in two resistant isolates. One isolate presented a S116F substitution in PiuC, and the other presented a deletion of 29 amino acids in the signal peptide of PiuA and a STOP substitution in PirA, resulting in the deletion of a piece of the channel. These mutations increased 24- and 64-folds the cefiderocol minimum inhibitory concentration, respectively. The mutations in the aforementioned genes may directly impact siderophore internalization, thereby contributing to an elevation in the MIC of the antibiotic. IMPORTANCECarbapenem-resistant Pseudomonas aeruginosa poses a significant challenge due to its broad antibiotic resistance. Cefiderocol is a novel antibiotic aimed at combating infections caused by such organisms. However, if these pathogens develop resistance to this new drug, it hinders treatment efficacy and options. Therefore, it is crucial to identify and describe mutations in the genes involved in the uptake of cefiderocol to find better treatment strategies for patients infected with multidrug-resistant P. aeruginosa.